These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25320504)

  • 1. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
    Matuszcak C; Haier J; Hummel R; Lindner K
    World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
    Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
    World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as potential biomarkers for gastric cancer.
    Liu HS; Xiao HS
    World J Gastroenterol; 2014 Sep; 20(34):12007-17. PubMed ID: 25232237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer.
    Riquelme I; Letelier P; Riffo-Campos AL; Brebi P; Roa JC
    Int J Mol Sci; 2016 Mar; 17(3):424. PubMed ID: 27011182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
    Shin VY; Chu KM
    World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
    Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
    World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors.
    Konoshenko M; Laktionov P
    Andrology; 2022 Jan; 10(1):51-71. PubMed ID: 34333834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance.
    Yuan L; Xu ZY; Ruan SM; Mo S; Qin JJ; Cheng XD
    Mol Cancer; 2020 May; 19(1):96. PubMed ID: 32460771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA signature associated with outcome of gastric cancer patients following chemotherapy.
    Kim CH; Kim HK; Rettig RL; Kim J; Lee ET; Aprelikova O; Choi IJ; Munroe DJ; Green JE
    BMC Med Genomics; 2011 Nov; 4():79. PubMed ID: 22112324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.
    Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J
    Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-induced drug resistance in gastric cancer.
    Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
    Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
    Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
    Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.